Transdermal fentanyl as an adjuvant to paravertebral block for pain control after breast cancer surgery: A randomized, double-blind controlled trial

Conclusion: TFPs releasing 25 μg/h is a safe and effective adjuvant to PVB after breast cancer surgery. It provides adequate analgesia with reduction of opioid consumption and minimal adverse effects.

Source: Saudi Journal of Anaesthesia - September 22, 2017 Category: Anesthesiology Authors: Ahmed H Bakeer Nasr M Abdallah Source Type: research